Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to learn if NDI-219216 is safe for patients, and if NDI-219216 might be a possible treatment for advanced solid tumors in the later phases of the study. The main qu...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Nimbus Wadjet, Inc.
Collaborators
NCT06974110 · Advanced Solid Tumor, Metastatic Solid Tumor, and more
NCT07259590 · Advanced Solid Tumors Cancer, PDAC, and more
NCT05483400 · Head and Neck Neoplasms, MSI-H Cancer, and more
NCT05651022 · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, and more
NCT02988960 · Advanced Solid Tumors Cancer
USC Norris Comprehensive Cancer Center
Los Angeles, California
University of Chicago Medicine
Chicago, Illinois
University of Louisville James Graham Brown Cancer Center
Louisville, Kentucky
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions